New Glioblastoma Treatment Reaches Human Brain Tumor and ... - News …
Jun 6, 2024 · In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy and immunotherapy drug cocktail.
‘Dramatic’ inroads against aggressive brain cancer - Harvard Gazette
Mar 14, 2024 · In a paper published Wednesday in The New England Journal of Medicine, researchers from Mass General Cancer Center shared the results for the first three patient cases from a Phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma.
Brain tumor vaccine: Experimental shot shows promise against glioblastoma
An experimental brain cancer vaccine improved survival time in patients with glioblastoma, the deadliest type of brain tumor. The vaccine, called SurVaxM, was shown to nearly double the survival...
New glioblastoma treatment reaches human brain tumor and …
Jun 6, 2024 · In a major advance for the treatment of the deadly brain cancer glioblastoma, scientists used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy...
Breakthrough Therapy Obliterates Deadly Brain Tumor in Days
Mar 15, 2024 · Brain scans of a 72-year-old man diagnosed with a highly aggressive form of cancer known as a glioblastoma have revealed a remarkable regression in his tumor's size within days of receiving an infusion of an innovative new treatment.
“Dual-Target” cell therapy appears to shrink brain tumors
Mar 13, 2024 · PHILADELPHIA— Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain cancer, according to early results from the first six patients treated in an ongoing Phase I clinical ...
New possibilities for treating intractable brain tumors unveiled
22 hours ago · DOI: 10.1136/jitc-2024-009449. Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in cancer treatment. However, in the case ...
Preliminary Clinical Trial Results Show ‘Dramatic and Rapid’ …
The trial, known as INCIPIENT, is designed to evaluate the safety of CARv3-TEAM-E T cells in patients with recurrent GBM. Just days after a single treatment, patients experienced dramatic reductions in their tumors, with one patient achieving near-complete tumor regression.
Powerful chemotherapy drug reaches brain tumors using novel …
May 3, 2023 · A major impediment to treating the deadly brain cancer glioblastoma has been that the most potent chemotherapy can’t permeate the blood-brain barrier to reach the aggressive brain tumor.
In two early trials, blood cancer treatment appears ... - NBC News
Mar 13, 2024 · Two early trials published Wednesday showed promise in treating one of the deadliest types of cancer, glioblastoma. The aggressive brain cancer, which took the lives of John McCain and Beau...